[ad_1] Global pharmaceutical giant Lupin Ltd. on Monday announced a significant milestone in its expansion strategy within the US market, securing tentative approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Amifampridine Tablets, 10 mg. This approval positions Lupin to tap into a substantial market opportunity […]
Headline
Tag: amifampridine tablets
Back To Top